A multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer (mCRC)A. Antonio, Federica Perrone, Guglielmo Nasti et al.|Annals of Oncology|2016Cited by 0